Clinical trial

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection

NCT02457611

Study summary

ClinicalTrials.gov

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention LDV/SOF Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-06-01

PhasePHASE2

Conditions

Hepatitis C Infection With HIV Co-Infectionunresolved

Interventions

LDV/SOFDRUG

Sponsors & collaborators

Gilead Scienceslead sponsor

Mapped research locations

LondonUnited Kingdom1 BerlinGermany1 BonnGermany1 Frankfurt am MainGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02457611 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.